• Enhancing brain neuromodulation. Gentle beneficial effects on levels of neurotransmitters: serotonin—related to mood, sexual function, appetite, sleep, memory, learning and some social behavior; melatonin—related to sleep-wake cycles; cortisol and DHEA—adrenal stress and steroid hormones.

• Central nervous system pain modulation. Beneficial effects on levels of neurotransmitters: endorphins and GABA—related to the the body’s natural pain relief mechanisms, and mediation and perception of pain.

• Brainwave augmentation. Stimulation frequencies in the beta brainwave band of the normal waking state of focused activity, decision-making and general alertness.

• Low voltage cranial electrotherapy. Far lower (1000×) millivolt magnitude stimulation achieves comparative or greater therapeutic effects than high magnitude voltage devices (typically: 20–30 volts). Safer, wider application, less risks of side effects, no unnecessary optic nerve stimulation or dizziness. Easier and more comfortable application—no wet sponge pads, tingling or burning under pads; less chance of skin irritation.

• Technological development of the Liss Cranial Modulated Electric Energy Stimulator USA patents. Auto-regulating stimulation intensity maintains therapeutic effect at real world, changing electrical circuit resistances when attached to the body.

• Australian patented & international application pending device & technology.